The Lustgarten Foundation exists to fund research for pancreatic cancer. We are committed to transforming pancreatic cancer into a curable disease and know research is fundamental to changing patient outcomes. In fact, it is the only way to give patients a better chance for long-term survival.
- Early Detection – The majority of pancreatic cancers are identified after the disease has metastasized, so we are committed to funding the world’s best early detection research.
- Personalized Medicine – Using individual genetic and tumor markers, doctors can create treatment strategies customized to each patient’s needs.
- New Drug Development – We fund research at every stage of the process from basic, pre-clinical research to clinical studies and trials.
Current Projects
The unwavering support of the Lustgarten community has enabled us to invest nearly $225 million in high-risk, high-reward science to launch clinical trials; fund new grant programs; expand existing collaborations, partnerships, and research initiatives; and take steps to honor our commitment to diversity, equity, and inclusion. Community is power and we are stronger because of you.
Read More
LABS: Lustgarten Advancing Breakthrough Science
Our LABS (Lustgarten Advancing Breakthrough Science) Program presents an unparalleled opportunity to increase collaboration between world-renowned pancreatic cancer researchers who are accelerating the pace of discovery. The program encourages researchers to explore promising avenues for understanding and treating pancreatic cancer and improving patient outcomes.
Read More
